{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T11:13:56Z","timestamp":1773573236647,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL157216"],"award-info":[{"award-number":["R01 HL157216"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["R01 HL168382"],"award-info":[{"award-number":["R01 HL168382"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["UL1 TR001873"],"award-info":[{"award-number":["UL1 TR001873"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K24 HL107643"],"award-info":[{"award-number":["K24 HL107643"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["K24 AG036778"],"award-info":[{"award-number":["K24 AG036778"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["T32 HL007854"],"award-info":[{"award-number":["T32 HL007854"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["2 National Clinical"],"award-info":[{"award-number":["2 National Clinical"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Population Research Awards"],"award-info":[{"award-number":["Population Research Awards"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Career Development Award"],"award-info":[{"award-number":["Career Development Award"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["Transformational Project Award"],"award-info":[{"award-number":["Transformational Project Award"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["W22005"],"award-info":[{"award-number":["W22005"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020066","name":"Feldstein Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014434","name":"Irving Medical Center, Columbia University","doi-asserted-by":"publisher","award":["Precision Medicine Pilot Award"],"award-info":[{"award-number":["Precision Medicine Pilot Award"]}],"id":[{"id":"10.13039\/100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014434","name":"Irving Medical Center, Columbia University","doi-asserted-by":"publisher","award":["Marjorie"],"award-info":[{"award-number":["Marjorie"]}],"id":[{"id":"10.13039\/100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014434","name":"Irving Medical Center, Columbia University","doi-asserted-by":"publisher","award":["Lewis Katz Cardiovascular Research Prize"],"award-info":[{"award-number":["Lewis Katz Cardiovascular Research Prize"]}],"id":[{"id":"10.13039\/100014434","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Cardiovasc. Transl. Res."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s12265-025-10618-x","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T15:26:13Z","timestamp":1744644373000},"page":"650-659","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comprehensive Plasma Proteomic Profiling Reveals Differentially Regulated Signaling Pathways Underlying Left Ventricular Hypertrophy Between Hypertrophic Cardiomyopathy and Aortic Stenosis"],"prefix":"10.1007","volume":"18","author":[{"given":"Heidi S.","family":"Lumish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo R.","family":"Sewanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lusha W.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muredach P.","family":"Reilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi J.","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"10618_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: Genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121:749\u201370. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311059.","journal-title":"Circ Res"},{"key":"10618_CR2","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1161\/ATVBAHA.119.313067","volume":"40","author":"PR Goody","year":"2020","unstructured":"Goody PR, Hosen MR, Christmann D, Niepmann ST, Zietzer A, Adam M, Bonner F, Zimmer S, Nickenig G, Jansen F. Aortic valve stenosis: From basic mechanisms to novel therapeutic targets. Arterioscler Thromb Vasc Biol. 2020;40:885\u2013900. https:\/\/doi.org\/10.1161\/ATVBAHA.119.313067.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10618_CR3","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cvr\/cvu205","volume":"104","author":"L Han","year":"2014","unstructured":"Han L, Li Y, Tchao J, Kaplan AD, Lin B, Li Y, Mich-Basso J, Lis A, Hassan N, London B, Bett GC, Tobita K, Rasmusson RL, Yang L. Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells. Cardiovasc Res. 2014;104:258\u201369. https:\/\/doi.org\/10.1093\/cvr\/cvu205.","journal-title":"Cardiovasc Res"},{"key":"10618_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jtcvs.2011.04.044","volume":"143","author":"WM Yarbrough","year":"2012","unstructured":"Yarbrough WM, Mukherjee R, Ikonomidis JS, Zile MR, Spinale FG. Myocardial remodeling with aortic stenosis and after aortic valve replacement: Mechanisms and future prognostic implications. J Thorac Cardiovasc Surg. 2012;143:656\u201364. https:\/\/doi.org\/10.1016\/j.jtcvs.2011.04.044.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10618_CR5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s12265-019-09896-z","volume":"12","author":"YJ Shimada","year":"2019","unstructured":"Shimada YJ, Hasegawa K, Kochav SM, Mohajer P, Jung J, Maurer MS, Reilly MP, Fifer MA. Application of proteomics profiling for biomarker discovery in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2019;12:569\u201379. https:\/\/doi.org\/10.1007\/s12265-019-09896-z.","journal-title":"J Cardiovasc Transl Res"},{"key":"10618_CR6","doi-asserted-by":"publisher","first-page":"e007849","DOI":"10.1161\/CIRCHEARTFAILURE.120.007849","volume":"14","author":"YJ Shimada","year":"2021","unstructured":"Shimada YJ, Raita Y, Liang LW, Maurer MS, Hasegawa K, Fifer MA, Reilly MP. Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy. Circ Heart Fail. 2021;14:e007849. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.120.007849.","journal-title":"Circ Heart Fail"},{"key":"10618_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1136\/heartjnl-2021-320729","volume":"108","author":"LW Liang","year":"2022","unstructured":"Liang LW, Raita Y, Hasegawa K, Fifer MA, Maurer MS, Reilly MP, Shimada YJ. Proteomics profiling reveals a distinct high-risk molecular subtype of hypertrophic cardiomyopathy. Heart. 2022;108:1807\u201314. https:\/\/doi.org\/10.1136\/heartjnl-2021-320729.","journal-title":"Heart"},{"issue":"24","key":"10618_CR8","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1136\/heartjnl-2023-322644","volume":"109","author":"HS Lumish","year":"2023","unstructured":"Lumish HS, Liang LW, Hasegawa K, Maurer MS, Fifer MA, Reilly MP, Shimada YJ. Prediction of worsening heart failure in hypertrophic cardiomyopathy using plasma proteomics. Heart. 2023;109(24):1837\u201343. https:\/\/doi.org\/10.1136\/heartjnl-2023-322644.","journal-title":"Heart"},{"key":"10618_CR9","doi-asserted-by":"publisher","first-page":"e003546","DOI":"10.1161\/CIRCGEN.121.003546","volume":"15","author":"YJ Shimada","year":"2022","unstructured":"Shimada YJ, Raita Y, Liang LW, Maurer MS, Hasegawa K, Fifer MA, Reilly MP. Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. Circ Genom Precis Med. 2022;15:e003546. https:\/\/doi.org\/10.1161\/CIRCGEN.121.003546.","journal-title":"Circ Genom Precis Med"},{"key":"10618_CR10","doi-asserted-by":"publisher","first-page":"839409","DOI":"10.3389\/fcvm.2022.839409","volume":"9","author":"BS Lander","year":"2022","unstructured":"Lander BS, Zhao Y, Hasegawa K, Maurer MS, Tower-Rader A, Fifer MA, Reilly MP, Shimada YJ. Comprehensive proteomics profiling identifies patients with late gadolinium enhancement on cardiac magnetic resonance imaging in the hypertrophic cardiomyopathy population. Front Cardiovasc Med. 2022;9:839409. https:\/\/doi.org\/10.3389\/fcvm.2022.839409.","journal-title":"Front Cardiovasc Med"},{"key":"10618_CR11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1136\/hrt.77.2.130","volume":"77","author":"WJ McKenna","year":"1997","unstructured":"McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: Proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:130\u20132. https:\/\/doi.org\/10.1136\/hrt.77.2.130.","journal-title":"Heart"},{"key":"10618_CR12","doi-asserted-by":"publisher","first-page":"e558","DOI":"10.1161\/CIR.0000000000000937","volume":"142","author":"SR Ommen","year":"2020","unstructured":"Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: A report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2020;142:e558\u2013631. https:\/\/doi.org\/10.1161\/CIR.0000000000000937.","journal-title":"Circulation"},{"key":"10618_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/s12350-016-0610-4","volume":"25","author":"S Bokhari","year":"2018","unstructured":"Bokhari S, Morgenstern R, Weinberg R, Kinkhabwala M, Panagiotou D, Castano A, DeLuca A, Kontak A, Jin Z, Maurer MS. Standardization of (99m)Technetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis. J Nucl Cardiol. 2018;25:181\u201390. https:\/\/doi.org\/10.1007\/s12350-016-0610-4.","journal-title":"J Nucl Cardiol"},{"key":"10618_CR14","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.echo.2017.02.009","volume":"30","author":"H Baumgartner","year":"2017","unstructured":"Baumgartner H, Hung J, Bermejo J, Chambers JB, Edvardsen T, Goldstein S, Lancellotti P, LeFevre M, Miller F Jr, Otto CM. Recommendations on the echocardiographic assessment of aortic valve stenosis: A focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. J Am Soc Echocardiogr. 2017;30:372\u201392. https:\/\/doi.org\/10.1016\/j.echo.2017.02.009.","journal-title":"J Am Soc Echocardiogr"},{"key":"10618_CR15","doi-asserted-by":"publisher","first-page":"e15004","DOI":"10.1371\/journal.pone.0015004","volume":"5","author":"L Gold","year":"2010","unstructured":"Gold L, Ayers D, Bertino J, Bock C, Bock A, Brody EN, Carter J, Dalby AB, Eaton BE, Fitzwater T, Flather D, Forbes A, Foreman T, Fowler C, Gawande B, Goss M, Gunn M, Gupta S, Halladay D, Heil J, Heilig J, Hicke B, Husar G, Janjic N, Jarvis T, Jennings S, Katilius E, Keeney TR, Kim N, Koch TH, Kraemer S, Kroiss L, Le N, Levine D, Lindsey W, Lollo B, Mayfield W, Mehan M, Mehler R, Nelson SK, Nelson M, Nieuwlandt D, Nikrad M, Ochsner U, Ostroff RM, Otis M, Parker T, Pietrasiewicz S, Resnicow DI, Rohloff J, Sanders G, Sattin S, Schneider D, Singer B, Stanton M, Sterkel A, Stewart A, Stratford S, Vaught JD, Vrkljan M, Walker JJ, Watrobka M, Waugh S, Weiss A, Wilcox SK, Wolfson A, Wolk SK, Zhang C, Zichi D. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE. 2010;5:e15004. https:\/\/doi.org\/10.1371\/journal.pone.0015004.","journal-title":"PLoS ONE"},{"key":"10618_CR16","first-page":"S5","volume":"24","author":"P Hensley","year":"2013","unstructured":"Hensley P. SOMAmers and SOMAscan \u2013 A protein biomarker discovery platform for rapid analysis of sample collections from bench top to the clinic. J Biomol Tech. 2013;24:S5.","journal-title":"J Biomol Tech"},{"key":"10618_CR17","doi-asserted-by":"publisher","first-page":"e26332","DOI":"10.1371\/journal.pone.0026332","volume":"6","author":"S Kraemer","year":"2011","unstructured":"Kraemer S, Vaught JD, Bock C, Gold L, Katilius E, Keeney TR, Kim N, Saccomano NA, Wilcox SK, Zichi D, Sanders GM. From SOMAmer-based biomarker discovery to diagnostic and clinical applications: A SOMAmer-based, streamlined multiplex proteomic assay. PLoS ONE. 2011;6:e26332. https:\/\/doi.org\/10.1371\/journal.pone.0026332.","journal-title":"PLoS ONE"},{"key":"10618_CR18","doi-asserted-by":"publisher","first-page":"H798","DOI":"10.1152\/ajpheart.00497.2021","volume":"322","author":"M Ward","year":"2022","unstructured":"Ward M, Yeganegi A, Baicu CF, Bradshaw AD, Spinale FG, Zile MR, Richardson WJ. Ensemble machine learning model identifies patients with HFpEF from matrix-related plasma biomarkers. Am J Physiol Heart Circ Physiol. 2022;322:H798\u2013805. https:\/\/doi.org\/10.1152\/ajpheart.00497.2021.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10618_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura M, Sadoshima J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat Rev Cardiol. 2018;15:387\u2013407. https:\/\/doi.org\/10.1038\/s41569-018-0007-y.","journal-title":"Nat Rev Cardiol"},{"key":"10618_CR20","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10554-019-01563-3","volume":"35","author":"RY Parbhudayal","year":"2019","unstructured":"Parbhudayal RY, Guclu A, Zweerink A, Biesbroek PS, Croisille P, Clarysse P, Michels M, Stooker W, Vonk ABA, van der Ven PM, van Rossum AC, van der Velden J, Nijveldt R. Myocardial adaptation after surgical therapy differs for aortic valve stenosis and hypertrophic obstructive cardiomyopathy. Int J Cardiovasc Imaging. 2019;35:1089\u2013100. https:\/\/doi.org\/10.1007\/s10554-019-01563-3.","journal-title":"Int J Cardiovasc Imaging"},{"key":"10618_CR21","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1016\/j.athoracsur.2004.05.063","volume":"78","author":"SJ Deb","year":"2004","unstructured":"Deb SJ, Schaff HV, Dearani JA, Nishimura RA, Ommen SR. Septal myectomy results in regression of left ventricular hypertrophy in patients with hypertrophic obstructive cardiomyopathy. Ann Thorac Surg. 2004;78:2118\u201322. https:\/\/doi.org\/10.1016\/j.athoracsur.2004.05.063.","journal-title":"Ann Thorac Surg"},{"key":"10618_CR22","doi-asserted-by":"publisher","first-page":"e003756","DOI":"10.1161\/CIRCGEN.122.003756","volume":"16","author":"R Garmany","year":"2023","unstructured":"Garmany R, Bos JM, Tester DJ, Giudicessi JR, Dos Remedios CG, Dasari S, Nagaraj NK, Nair AA, Johnson KL, Ryan ZC, Maleszewski JJ, Ommen SR, Dearani JA, Ackerman MJ. Multi-omic architecture of obstructive hypertrophic cardiomyopathy. Circ Genom Precis Med. 2023;16:e003756. https:\/\/doi.org\/10.1161\/CIRCGEN.122.003756.","journal-title":"Circ Genom Precis Med"},{"key":"10618_CR23","doi-asserted-by":"publisher","first-page":"e2025030118","DOI":"10.1073\/pnas.2025030118","volume":"118","author":"AS Vander Roest","year":"2021","unstructured":"Vander Roest AS, Liu C, Morck MM, Kooiker KB, Jung G, Song D, Dawood A, Jhingran A, Pardon G, Ranjbarvaziri S, Fajardo G, Zhao M, Campbell KS, Pruitt BL, Spudich JA, Ruppel KM, Bernstein D. Hypertrophic cardiomyopathy beta-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state. Proc Natl Acad Sci U S A. 2021;118:e2025030118. https:\/\/doi.org\/10.1073\/pnas.2025030118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10618_CR24","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI44972","volume":"121","author":"TM Marin","year":"2011","unstructured":"Marin TM, Keith K, Davies B, Conner DA, Guha P, Kalaitzidis D, Wu X, Lauriol J, Wang B, Bauer M, Bronson R, Franchini KG, Neel BG, Kontaridis MI. Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation. J Clin Invest. 2011;121:1026\u201343. https:\/\/doi.org\/10.1172\/JCI44972.","journal-title":"J Clin Invest"},{"key":"10618_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1161\/hc2801.094031","volume":"104","author":"R Patel","year":"2001","unstructured":"Patel R, Nagueh SF, Tsybouleva N, Abdellatif M, Lutucuta S, Kopelen HA, Quinones MA, Zoghbi WA, Entman ML, Roberts R, Marian AJ. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 2001;104:317\u201324. https:\/\/doi.org\/10.1161\/hc2801.094031.","journal-title":"Circulation"},{"key":"10618_CR26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/cells11071249","volume":"11","author":"S Besse","year":"2022","unstructured":"Besse S, Nadaud S, Balse E, Pavoine C. Early protective role of inflammation in cardiac remodeling and heart failure: Focus on TNFalpha and resident macrophages. Cells. 2022;11:1249. https:\/\/doi.org\/10.3390\/cells11071249.","journal-title":"Cells"},{"key":"10618_CR27","first-page":"5063","volume":"9","author":"L Fang","year":"2017","unstructured":"Fang L, Ellims AH, Beale AL, Taylor AJ, Murphy A, Dart AM. Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy. Am J Transl Res. 2017;9:5063\u201373.","journal-title":"Am J Transl Res"},{"key":"10618_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40659-023-00451-4","volume":"56","author":"H Yu","year":"2023","unstructured":"Yu H, Gu L, Du L, Dong Z, Li Z, Yu M, Yin Y, Wang Y, Yu L, Ma H. Identification and analysis of key hypoxia- and immune-related genes in hypertrophic cardiomyopathy. Biol Res. 2023;56:45. https:\/\/doi.org\/10.1186\/s40659-023-00451-4.","journal-title":"Biol Res"},{"key":"10618_CR29","doi-asserted-by":"publisher","first-page":"e010010","DOI":"10.1161\/CIRCHEARTFAILURE.122.010010","volume":"16","author":"LW Liang","year":"2023","unstructured":"Liang LW, Hasegawa K, Maurer MS, Reilly MP, Fifer MA, Shimada YJ. Comprehensive transcriptomics profiling of microRNA reveals plasma circulating biomarkers of hypertrophic cardiomyopathy and dysregulated signaling pathways. Circ Heart Fail. 2023;16:e010010. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.122.010010.","journal-title":"Circ Heart Fail"},{"key":"10618_CR30","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/heartjnl-2011-300960","volume":"98","author":"J Kuusisto","year":"2012","unstructured":"Kuusisto J, Karja V, Sipola P, Kholova I, Peuhkurinen K, Jaaskelainen P, Naukkarinen A, Yla-Herttuala S, Punnonen K, Laakso M. Low-grade inflammation and the phenotypic expression of myocardial fibrosis in hypertrophic cardiomyopathy. Heart. 2012;98:1007\u201313. https:\/\/doi.org\/10.1136\/heartjnl-2011-300960.","journal-title":"Heart"},{"key":"10618_CR31","doi-asserted-by":"publisher","first-page":"e009521","DOI":"10.1161\/CIRCHEARTFAILURE.121.009521","volume":"15","author":"MJ Previs","year":"2022","unstructured":"Previs MJ, O\u2019Leary TS, Morley MP, Palmer BM, LeWinter M, Yob JM, Pagani FD, Petucci C, Kim MS, Margulies KB, Arany Z, Kelly DP, Day SM. Defects in the proteome and metabolome in human hypertrophic cardiomyopathy. Circ Heart Fail. 2022;15:e009521. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.121.009521.","journal-title":"Circ Heart Fail"},{"key":"10618_CR32","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","volume":"144","author":"S Ranjbarvaziri","year":"2021","unstructured":"Ranjbarvaziri S, Kooiker KB, Ellenberger M, Fajardo G, Zhao M, Vander Roest AS, Woldeyes RA, Koyano TT, Fong R, Ma N, Tian L, Traber GM, Chan F, Perrino J, Reddy S, Chiu W, Wu JC, Woo JY, Ruppel KM, Spudich JA, Snyder MP, Contrepois K, Bernstein D. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy. Circulation. 2021;144:1714\u201331. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.053575.","journal-title":"Circulation"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-025-10618-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-025-10618-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T14:29:47Z","timestamp":1751293787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-025-10618-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10618"],"URL":"https:\/\/doi.org\/10.1007\/s12265-025-10618-x","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We declare that we have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Subjects"}},{"value":"No animal studies were carried out by the authors for this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}},{"value":"Y.J.S. has received research funding from Bristol Myers Squibb and consulting income from Bristol Myers Squibb and Moderna Japan. M.S.M. has received consulting income from Akcea, Alnylam, Eidos Therapeutics, Pfizer, Prothena, Novo Nordisk, and Intellia.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"H.S.L., L.S., L.W.L., K.H., and M.P.R. declare they have no financial interests","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}